Rating Change
Maxim Group reiterated its Buy rating on NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) on August 14, 2026.
reiterateNASDAQ:NMTC
Maxim Group Reiterates Buy Rating on NeuroOne Medical Technologies Corporation (NMTC)
Maxim Group reiterated its Buy rating on NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) on August 14, 2026.
At publication ·
What changed
NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) · reiterate
- Firm
- Maxim Group
- Rating
- Buy to Buy
- Price at event
- $1.94
- Market capitalization
- $29.3M
At a glance
Key takeaways
- Maxim Group reiterated its Buy rating on NeuroOne Medical Technologies Corporation (NMTC) on August 14, 2026, with the stock trading at $1.94 and a market capitalization of $29.3 million.
Market Context
NeuroOne Medical Technologies Corporation operates in the Healthcare sector. The stock currently trades at $1.94 with a market capitalization of $29.3M.
Analyst coverage from Maxim Group provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for NeuroOne Medical Technologies Corporation.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for NeuroOne Medical Technologies Corporation
Among the 9 most recent ratings: 8 Buy, 1 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 14, 2026 | Maxim Group | Buy | N/A |
| May 13, 2026 | Ladenburg Thalmann | Buy | N/A |
| Mar 02, 2026 | Jones Trading | Buy | N/A |
| Sep 09, 2025 | Maxim Group | Buy | N/A |
| May 05, 2025 | Ladenburg Thalmann | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View NMTC Stock Page
Frequently Asked Questions
What does the Buy rating mean for NMTC?
A rating of Buy from Maxim Group reflects the analyst's outlook on NeuroOne Medical Technologies Corporation (NASDAQ:NMTC). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the NMTC forecast page.